Sector Gamma AS’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Sector Gamma AS’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-275,024	Closed	-$3.84M	–	40
2017 Q4	$3.84M	Sell	275,024 -45,031	-14%	-$609K	0.64%	30
2017 Q3	$5.92M	Sell	320,055 -285,490	-47%	-$4.77M	0.9%	25
2017 Q2	$10.2M	Sell	605,545 -151,220	-20%	-$2.3M	1.49%	22
2017 Q1	$10.1M	Sell	756,765 -98,500	-12%	-$1.54M	1.61%	21
2016 Q4	$12.9M	Sell	855,265 -103,614	-11%	-$1.37M	2.42%	18
2016 Q3	$10.6M	Buy	958,879 +43,900	+5%	+$516K	1.86%	21
2016 Q2	$9.88M	Buy	914,979 +134,666	+17%	+$1.39M	1.88%	21
2016 Q1	$7.21M	Buy	780,313 +355,777	+84%	+$3.83M	1.48%	22
2015 Q4	$6.3M	Buy	424,536 +73,616	+21%	+$1.23M	1.62%	22
2015 Q3	$5.76M	Buy	350,920 +210,480	+150%	+$4.31M	1.56%	22
2015 Q2	$3.2M	Sell	140,440 -34,660	-20%	-$690K	0.82%	23
2015 Q1	$2.66M	Buy	+175,100	New	+$2.28M	0.7%	25
2014 Q1	–	Sell	-136,800	Closed	-$2.42M	–	35
2013 Q4	$2.42M	Sell	136,800 -50,000	-27%	-$840K	0.65%	32
2013 Q3	$2.69M	Buy	186,800 +21,800	+13%	+$334K	0.69%	32
2013 Q2	$2.48M	Buy	+165,000	New	+$2.18M	0.72%	29

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sector Gamma AS's MNTA Position: Q1 2018 in Review

Sector Gamma AS sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2018, closing a stake of 275,024 shares — an estimated $3.84M sold.

Sector Gamma AS first reported a position in MNTA in Q2 2013 and held it in 15 quarters. The position peaked at $12.9M in Q4 2016. 163 funds tracked by Wall St. Rank hold MNTA as of Q1 2018.

Sector Gamma AS reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Sector Gamma AS sold 275,024 Momenta Pharmaceuticals, Inc. shares in Q1 2018, an estimated $3.84M.
Sector Gamma AS first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 15 quarters.
Sector Gamma AS's Momenta Pharmaceuticals, Inc. position peaked at $12.9M in Q4 2016.
163 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2018.

Based on Sector Gamma AS's 13F filing for Q1 2018, filed 9 May 2018.